UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Curcumin as a clinically-promising anti-cancer agent: pharmacokinetics and drug interactions

Expert opinion on drug metabolism & toxicology, 2017-09, Vol.13 (9), p.953-972

2017

Volltextzugriff (PDF)

Physiologically-Based Pharmacokinetic Predictions of the Effect of Curcumin on Metabolism of Imatinib and Bosutinib: In Vitro and In Vivo Disconnect

Pharmaceutical research, 2020-07, Vol.37 (7), p.128, Article 128

2020

Volltextzugriff (PDF)

Physiologically based pharmacokinetic model predictions of natural product-drug interactions between goldenseal, berberine, imatinib and bosutinib

European journal of clinical pharmacology, 2022-04, Vol.78 (4), p.597-611

2022

Volltextzugriff (PDF)

Implementation of a Physiologically Based Pharmacokinetic Modeling Approach to Guide Optimal Dosing Regimens for Imatinib and Potential Drug Interactions in Paediatrics

Frontiers in pharmacology, 2020-01, Vol.10, p.1672

2020

Volltextzugriff (PDF)

Investigating bile acid-mediated cholestatic drug-induced liver injury using a mechanistic model of multidrug resistance protein 3 (MDR3) inhibition

Frontiers in pharmacology, 2023-01, Vol.13, p.1085621

2023

Volltextzugriff (PDF)

Application of physiologically based pharmacokinetic modeling to understand real‐world outcomes in patients receiving imatinib for chronic myeloid leukemia

Pharmacology research & perspectives, 2023-08, Vol.11 (4), p.e01082-n/a

2023

Volltextzugriff (PDF)

Effect of Nigella sativa oil on pharmacokinetics and pharmacodynamics of gliclazide in rats

Biopharmaceutics & drug disposition, 2021-09, Vol.42 (8), p.359-371

2021

Volltextzugriff (PDF)

Physiologically Based Pharmacokinetic

Pharmaceutical research, 2024-03, Vol.41 (3), p.441

2024

Volltextzugriff (PDF)

Potential for pharmacokinetic interactions between Schisandra sphenanthera and bosutinib, but not imatinib: in vitro metabolism study combined with a physiologically‐based pharmacokinetic modelling approach

British journal of clinical pharmacology, 2020-10, Vol.86 (10), p.2080-2094

2020

Volltextzugriff (PDF)

Physiologically Based Pharmacokinetic (PBPK) Model Predictions of Disease Mediated Changes in Drug Disposition in Patients with Nonalcoholic Fatty Liver Disease (NAFLD)

Pharmaceutical research, 2024-03, Vol.41 (3), p.441-462

2024

Volltextzugriff (PDF)

Interactions between natural products and cancer treatments: underlying mechanisms and clinical importance

Cancer chemotherapy and pharmacology, 2023-02, Vol.91 (2), p.103-119

2023

Volltextzugriff (PDF)

Physiologically Based Pharmacokinetic Modelling of Hyperforin to Predict Drug Interactions with St John’s Wort

Clinical pharmacokinetics, 2019-07, Vol.58 (7), p.911-926

2019

Volltextzugriff (PDF)

Considerations for Physiologically Based Modeling in Liver Disease: From Nonalcoholic Fatty Liver (NAFL) to Nonalcoholic Steatohepatitis (NASH)

Clinical pharmacology and therapeutics, 2023-02, Vol.113 (2), p.275-297

2023

Volltextzugriff (PDF)

Physiologically‐based pharmacokinetic model predictions of inter‐ethnic differences in imatinib pharmacokinetics and dosing regimens

British journal of clinical pharmacology, 2022-02, Vol.88 (4), p.1735-1750

2022

Volltextzugriff (PDF)

Physiologically Based Pharmacokinetic Modeling Approaches for Patients With SARS‐CoV‐2 Infection: A Case Study With Imatinib

Journal of clinical pharmacology, 2022-10, Vol.62 (10), p.1285-1296

2022

Volltextzugriff (PDF)

Simultaneous HPLC Assay of Gliclazide and Ciprofloxacin in Plasma and its Implementation for Pharmacokinetic Study in Rats

Journal of chromatographic science, 2021-03, Vol.59 (4), p.338-346

2021

Volltextzugriff (PDF)

Pharmacokinetic assessment of constituents of Boswellia serrata, pine bark extracts, curcumin in combination including methylsulfonylmethane in healthy volunteers

Journal of pharmacy and pharmacology, 2020-01, Vol.72 (1), p.121-131

2020

Volltextzugriff (PDF)

A Strategy to Refine the Phenotyping Approach and Its Implementation to Predict Drug Clearance: A Physiologically Based Pharmacokinetic Simulation Study

CPT: pharmacometrics and systems pharmacology, 2018-12, Vol.7 (12), p.798-808

2018

Volltextzugriff (PDF)

Pharmacokinetics of Biologics

Biologics, Biosimilars, and Biobetters, 2021, p.125-145

2021

Volltextzugriff (PDF)

DRUG TRANSPORT IN THE LIVER

Drug Transporters, 2022, p.257-282

2022

Volltextzugriff (PDF)

1 – 20 von 20

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(18)
Mit Volltextzugriff
(18)

Publikationsform

Artikel
(18)
Buchkapitel
(2)

Sprache

Englisch
(20)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(16)
Science & Technology
(16)
Pharmacology & Pharmacy
(15)
Pharmacokinetics
(11)
Enzymes
(7)
Humans
(7)
Imatinib
(6)
Drug Dosages
(5)
Drug Interactions
(5)
Metabolism
(5)
Pharmacology/toxicology
(5)
Glycoproteins
(4)
Models, Biological
(4)
Pharmacodynamics
(4)
Pharmacology
(4)
Physiologically Based Pharmacokinetic
(4)
Simulation
(4)
Animals
(3)
Bioavailability
(3)
Biomedical And Life Sciences
(3)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Curcumin as a clinically-promising anti-cancer agent: pharmacokinetics and drug interactions

Physiologically-Based Pharmacokinetic Predictions of the Effect of Curcumin on Metabolism of Imatinib and Bosutinib: In Vitro and In Vivo Disconnect

Physiologically based pharmacokinetic model predictions of natural product-drug interactions between goldenseal, berberine, imatinib and bosutinib

Implementation of a Physiologically Based Pharmacokinetic Modeling Approach to Guide Optimal Dosing Regimens for Imatinib and Potential Drug Interactions in Paediatrics

Investigating bile acid-mediated cholestatic drug-induced liver injury using a mechanistic model of multidrug resistance protein 3 (MDR3) inhibition

Application of physiologically based pharmacokinetic modeling to understand real‐world outcomes in patients receiving imatinib for chronic myeloid leukemia

Effect of Nigella sativa oil on pharmacokinetics and pharmacodynamics of gliclazide in rats

Physiologically Based Pharmacokinetic

Potential for pharmacokinetic interactions between Schisandra sphenanthera and bosutinib, but not imatinib: in vitro metabolism study combined with a physiologically‐based pharmacokinetic modelling approach

Physiologically Based Pharmacokinetic (PBPK) Model Predictions of Disease Mediated Changes in Drug Disposition in Patients with Nonalcoholic Fatty Liver Disease (NAFLD)

Interactions between natural products and cancer treatments: underlying mechanisms and clinical importance

Physiologically Based Pharmacokinetic Modelling of Hyperforin to Predict Drug Interactions with St John’s Wort

Considerations for Physiologically Based Modeling in Liver Disease: From Nonalcoholic Fatty Liver (NAFL) to Nonalcoholic Steatohepatitis (NASH)

Physiologically‐based pharmacokinetic model predictions of inter‐ethnic differences in imatinib pharmacokinetics and dosing regimens

Physiologically Based Pharmacokinetic Modeling Approaches for Patients With SARS‐CoV‐2 Infection: A Case Study With Imatinib

Simultaneous HPLC Assay of Gliclazide and Ciprofloxacin in Plasma and its Implementation for Pharmacokinetic Study in Rats

Pharmacokinetic assessment of constituents of Boswellia serrata, pine bark extracts, curcumin in combination including methylsulfonylmethane in healthy volunteers

A Strategy to Refine the Phenotyping Approach and Its Implementation to Predict Drug Clearance: A Physiologically Based Pharmacokinetic Simulation Study

Pharmacokinetics of Biologics

DRUG TRANSPORT IN THE LIVER

Suchergebnisse filtern